Arine empowers health plans and providers with comprehensive medication management that helps patients live their healthiest lives.
Total raised: $70M
Investors 5
| Date | Name | Website |
| - | Super Capi... | supercapgr... |
| - | Katalyst V... | katalyst.v... |
| 17.10.2025 | Kaiser Per... | kpventures... |
| 25.10.2023 | MBX Capita... | mbxcapital... |
| - | Rock Healt... | rockhealth... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 24.06.2025 | Series C | $30M | - |
| 17.08.2022 | Series B | $29M | - |
| 26.10.2021 | - | $11M | - |
Mentions in press and media 11
| Date | Title | Description |
| 18.10.2025 | Town Hall Ventures Secures $440M Fund IV to Ignite AI-Driven Health Equity | Town Hall Ventures unveiled its new $440 million Fund IV. This significant capital infusion targets AI-driven healthcare solutions. The core mission remains serving underserved communities across the United States. Fund IV aims to lower hea... |
| 16.10.2025 | Town Hall Ventures: $440 Million Fund IV Raised To Advance AI-Driven Healthcare for Underserved Communities | Town Hall Ventures announced the launch of its fourth fund, securing approximately $440 million in capital commitments to advance innovation in healthcare for underserved communities across the US. The new fund will build on the firm’s miss... |
| 25.06.2025 | Arine's $30M Funding: A Game Changer in Medication Management | In the bustling heart of San Francisco, a revolution is brewing in healthcare. Arine, an AI-driven medication intelligence company, has just secured $30 million in Series C funding. This round was led by Town Hall Ventures, with Kaiser Perm... |
| 24.06.2025 | Arine Raises $30M in Series C Funding | Arine, a San Francisco, CA-based AI-driven medication intelligence company, raised $30M in Series C funding. The round was led by Town Hall Ventures, with participation from Kaiser Permanente Ventures and other existing investors. The compa... |
| 24.06.2025 | Arine Raises $30M to Redefine Medication Management with AI | What You Should Know: – Arine, the leader in AI-driven medication intelligence announced it has closed a $30M Series C funding round led by Town Hall Ventures, with participation from Kaiser Permanente Ventures and other existing investors.... |
| 15.01.2025 | Overprescribing and Polypharmacy: Arine CEO Talks The Hidden Dangers of Amazon’s Same-Day Prescription Delivery | Yoona Kim, Founder & CEO at Arine As ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five... |
| 19.08.2022 | Medication Intelligence Startup Arine Raises $29M | What You Should Know: |
| 17.08.2022 | Arine Raises $29M in Series B Funding | Arine, a San Francisco, CA-based medication intelligence company, raised $29M Series B funding. The round was led by 111° West Capital, with participation from MBX Capital, New Leaf Venture Partners, Katalyst Ventures and Super Capital Grou... |
| 15.02.2022 | Arine Raises $11M Series A to Scale Medication Optimization Platform | - |
| 26.10.2021 | Arine Raises $11M to Scale AI-Driven Medication Optimization Platform | What You Should Know: – Arine, a San Francisco-based AI-driven platform that optimizes medication management, reduces costs and improves outcomes for health plans and providers today announced that it closed $11 million in an oversubscribed... |
Show more